2023-05-19 17:35:49 ET
- Clearmind Medicine ( NASDAQ: CMND ) on Friday said it had got a notice that it was not in compliance with a Nasdaq listing rule on minimum bid price.
- The rule requires listed securities to maintain a minimum bid price of $1.00/share.
- CMND has been granted a grace period of 180 calendar days to regain compliance with the minimum bid price requirement.
- The Nasdaq notice does not immediately affect CMND's listing or the trading of its ordinary shares, the company said in a statement .
For further details see:
Clearmind gets Nasdaq non-compliance notice on minimum bid price requirement